Rejection of drug a blow for Australians living with Alzheimer’s disease
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
A new treatment for people living with the early stages of Alzheimer’s disease or mild cognitive impairment has been rejected by the Therapeutic Goods Administration (TGA).
With Dementia becoming the leading cause of death in Australia, it’s disappointing news for those impacted by Alzheimers.
Guest: Dr Kaele Stokes is Dementia Australia’s Executive Director – Services, Advocacy & Research.
Presenter: Warren Andrew.
Podcast: Play in new window | Download (Duration: 9:45 — 13.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
RECENT PODCAST
Nicole Rich: Property Underquoting
Underquoting has become a flashpoint for frustrated buyers and confused sellers, especially as some properties continue to sell far above ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 14:19 — 19.7MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Elliot Attard: Gaming News
From surprise drops to messy patches and the next wave of must-play titles, the gaming world is bursting with updates. ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 13:18 — 18.3MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS
Suzy Wrong: TV Series Review – Boots
Suzy Wrong reviews Netflix’s Boots, which dives into big life pivots, belonging, and the fear of being “too late”. Guest: Suzy ...
LISTEN TO PODCAST NOW
Podcast: Play in new window | Download (Duration: 18:30 — 25.4MB)
Subscribe or Follow Us: Apple Podcasts | Spotify | RSS